We are live on ! Find out more
IFA

Invus Financial Advisors Portfolio holdings

AUM $89.2M
1-Year Est. Return 10.79%
This Fund
S&P 500
This Quarter Est. Return
+29.89%
1 Year Est. Return
-10.79%
3 Year Est. Return
-29.46%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$277M
AUM Growth
+$73M
Cap. Flow
+$37.5M
Cap. Flow %
13.57%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
1
Reduced
–
Closed
–
Avg Time Held
1.4 quarters
Top 10 Avg Time Held
1.4 quarters
Top 20 Avg Time Held
1.4 quarters

Top Buys

Rank Stock Value
1
ORIC icon
Oric Pharmaceuticals
ORIC
+$32.2M
2
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
+$5.38M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 74.62%
2 Technology 25.05%
3 Consumer Staples 0.24%
4 Consumer Discretionary 0.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
OYST
1
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$80M 28.9%
2,768,586
+178,571
+7% +$5.38M
2019 Q4
2 quarters
YEXT icon
2
Yext
YEXT
$693M
$68.9M 24.89%
4,146,784
– –
2019 Q4
2 quarters
RCUS icon
3
Arcus Biosciences
RCUS
$2.87B
$45.6M 16.47%
1,842,077
– –
2019 Q4
2 quarters
ORIC icon
4
Oric Pharmaceuticals
ORIC
$1.17B
$34M 12.28%
+1,007,576
New +$32.2M
2020 Q2
0 quarters
NVCR icon
5
NovoCure
NVCR
$1.67B
$27.9M 10.09%
470,884
– –
2019 Q4
2 quarters
UBX icon
6
DELISTED
Unity Biotechnology
UBX
$19M 6.87%
219,000
– –
2019 Q4
2 quarters
CHGG icon
7
Chegg
CHGG
$79.2M
$664K 0.24%
9,868
– –
2020 Q1
1 quarter
RUN icon
8
Sunrun
RUN
$1.88B
$427K 0.15%
21,657
– –
2020 Q1
1 quarter
BABA icon
9
Alibaba
BABA
$276B
$261K 0.09%
1,211
– –
2020 Q1
1 quarter

Similar funds

ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
CC
Cowbird Capital New York $87M AUM 10.91% 1-Year Est. Return
OAMA
Oslo Asset Management AS Oslo, Norway $86.5M AUM 12.57% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Invus Financial Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Invus Financial Advisors held 9 positions worth $277M, up 36% from $204M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Invus Financial Advisors deployed $37.5M of net new capital in Q2 2020, opening 1 new position and adding to 1 existing holding. Its largest new stake was Oric Pharmaceuticals: 1,007,576 shares worth $34M.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, down from 79% a quarter earlier, followed by Technology and Consumer Staples.

  • Invus Financial Advisors's largest Q2 2020 buy was Oric Pharmaceuticals: 1,007,576 shares worth $34M.
  • Invus Financial Advisors added most to Oyster Point Pharma, Inc. Common Stock in Q2 2020, an estimated $5.38M increase.
  • Invus Financial Advisors's ten largest holdings make up 100% of its $277M portfolio in Q2 2020.
  • Invus Financial Advisors opened 1 new position and closed 0 in Q2 2020.
  • Invus Financial Advisors's portfolio value rose 36% quarter-over-quarter to $277M.

Based on Invus Financial Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.